ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 761

$637K Total Retail Price of All Prescriptions

Rank: 59 out of 761

581 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 11,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 709 634 1 1
SIMVASTATIN 610 515 2 2
OMEPRAZOLE 516 414 3 4
HYDROCODONE-ACETAMINOPHEN 511 418 S3 4 5
LEVOTHYROXINE SODIUM 500 464 5 3
AMLODIPINE BESYLATE 438 415 6 6
FUROSEMIDE 392 350 7 7
METFORMIN HCL 378 315 8 10
TRAZODONE HCL 323 261 9 23
LOSARTAN POTASSIUM 283 277 10 13
POTASSIUM CHLORIDE 264 245 11 18
WARFARIN SODIUM 246 242 12 9
GABAPENTIN 233 217 13 15
HYDROCHLOROTHIAZIDE 215 194 14 11
CITALOPRAM HBR 210 163 15 19
TAMSULOSIN HCL 183 143 16 27
METOPROLOL SUCCINATE 182 169 17 16
ATENOLOL 176 158 18 8
METOPROLOL TARTRATE 171 163 19 14
PRAVASTATIN SODIUM 169 144 20 20
RISPERIDONE 167 140 21 83
SERTRALINE HCL 165 140 22 25
NAMENDA 163 163 23 59
ATORVASTATIN CALCIUM 161 137 24 12
ALLOPURINOL 155 131 25 28
OXYCODONE HCL 150 102 S2 26 24
FAMOTIDINE 148 137 27 60
DONEPEZIL HCL 132 130 28 33
PROAIR HFA 125 82 29 32
FLUOXETINE HCL 122 76 30 31
PREDNISONE 120 88 31 30
CARVEDILOL 116 104 32 26
CYCLOBENZAPRINE HCL 113 57 R 33 51
MORPHINE SULFATE ER 112 74 S2 34 38
AZITHROMYCIN 103 89 35 70
LANTUS 102 94 36 41
GLIMEPIRIDE 102 85 36 48
LOVASTATIN 100 96 38 17
POLYETHYLENE GLYCOL 3350 94 72 39 62
ALENDRONATE SODIUM 93 92 40 21
NAPROXEN 90 35 41 105
DIGOXIN 88 88 42 43
MIRTAZAPINE 82 52 43 50
ZOLPIDEM TARTRATE 81 54 44 22
SPIRONOLACTONE 77 58 45 45
PANTOPRAZOLE SODIUM 73 67 46 40
CIPROFLOXACIN HCL 73 64 46 63
LOSARTAN-HYDROCHLOROTHIAZIDE 72 49 48 65
PAROXETINE HCL 69 37 49 47
AMITRIPTYLINE HCL 67 59 R 50 54
FLUTICASONE PROPIONATE 65 40 51 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 52 52 35
CEPHALEXIN 64 58 52 145
QUETIAPINE FUMARATE 58 39 54 90
FENTANYL 57 51 S2 55 57
ISOSORBIDE MONONITRATE ER 56 56 56 72
OXYCODONE HCL-ACETAMINOPHEN 54 29 S2 57 136
OLANZAPINE 53 49 58 144
DIVALPROEX SODIUM 52 40 59 97
CLOPIDOGREL 51 41 60 66
DIOVAN 51 48 60 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 36 62 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.